Pembrolizumab-induced benign atypical intralymphatic CD30+ T-cell proliferation mimicking intravascular lymphoma

Wei Kai Hung; Chun Bing Chen; Tseng tong Kuo; Wei Ti Chen

doi:10.1111/1346-8138.16166

Pembrolizumab-induced benign atypical intralymphatic CD30⁺ T-cell proliferation mimicking intravascular lymphoma

Wei Kai Hung
, Chun Bing Chen
, Tseng tong Kuo
, Wei Ti Chen^*

^*Corresponding author for this work

Research output: Contribution to journal › Journal Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	e53-e54
Journal	Journal of Dermatology
Volume	49
Issue number	2
DOIs	https://doi.org/10.1111/1346-8138.16166
State	Published - 02 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/1346-8138.16166

Cite this

@article{abf172d49785472e97e85bbb91eb29ef,

title = "Pembrolizumab-induced benign atypical intralymphatic CD30+ T-cell proliferation mimicking intravascular lymphoma",

author = "Hung, \{Wei Kai\} and Chen, \{Chun Bing\} and Kuo, \{Tseng tong\} and Chen, \{Wei Ti\}",

year = "2022",

month = feb,

doi = "10.1111/1346-8138.16166",

language = "英语",

volume = "49",

pages = "e53--e54",

journal = "Journal of Dermatology",

issn = "0385-2407",

publisher = "John Wiley and Sons Inc",

number = "2",

}

TY - JOUR

T1 - Pembrolizumab-induced benign atypical intralymphatic CD30+ T-cell proliferation mimicking intravascular lymphoma

AU - Hung, Wei Kai

AU - Chen, Chun Bing

AU - Kuo, Tseng tong

AU - Chen, Wei Ti

PY - 2022/2

Y1 - 2022/2

UR - https://www.scopus.com/pages/publications/85115788835

U2 - 10.1111/1346-8138.16166

DO - 10.1111/1346-8138.16166

M3 - 快报

C2 - 34580915

AN - SCOPUS:85115788835

SN - 0385-2407

VL - 49

SP - e53-e54

JO - Journal of Dermatology

JF - Journal of Dermatology

IS - 2

ER -

Pembrolizumab-induced benign atypical intralymphatic CD30+ T-cell proliferation mimicking intravascular lymphoma

UN SDGs

Access to Document

Other files and links

Cite this

Pembrolizumab-induced benign atypical intralymphatic CD30⁺ T-cell proliferation mimicking intravascular lymphoma